Neuroblastoma: open trials in Spain

10 open trials have a site in Spain. Registry data; only the trial team decides who can take part.

NCT07549321
A Safety and Efficacy Study of hu14 in High-Risk Neuroblastoma Patients
Trial Treatment · Phase 2/3 · Renaissance Pharma Ltd.
Hospital Sant Joan de Déu, Barcelona · University Hospital Vall d'Hebron, Barcelona · Hospital Infantil Universitario Nino Jesus, Madrid
Registry updated 2026-11-03
NCT06395103
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Hospital Universitari Vall d'Hebron, Barcelona · Sant Joan De Deu Barcelona Hospital, Esplugues De Llobregat · Hospital Infantil Universitario Nino Jesus, Madrid · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-10-30
NCT05489887
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Trial Treatment · Phase 2 · Giselle Sholler
Hospital Sant Joan De Deu Barcelona, Esplugues de Llobregat
Registry updated 2026-08-12
NCT06607692
Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).
Trial Treatment · Phase 1/2 · Fundación de investigación HM
HM Monteprincipe, Boadilla del Monte
Registry updated 2026-06-04
2023-504880-18-00
A phase 1B of crizotinib either in combination or as single agent in pediatric patients with ALK, ROS1 or MET positive malignancies
Trial Treatment · Phase 1/2 · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Fir Huvh Fundacio Institut De Recerca Hospital Universitari Vall De Hebron, Barcelona · Hospital Infantil Universitario Nino Jesus, Madrid · University Hospital Virgen Del Rocio S.L., Sevilla · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-05-07
2023-504246-64-02
A phase I/II trial of ABTL0812 in children with relapsed/refractory neuroblastoma and other solid tumours
Trial Treatment · Phase 1/2 · Fir Huvh Fundacio Institut De Recerca Hospital Universitari Vall De Hebron
Hospital Universitario de Cruces, Barakaldo · Hospital Universitari Vall d'Hebron, Barcelona · Sant Joan De Deu Barcelona Hospital, Esplugues De Llobregat · Hospital Universitario La Paz, Madrid · Hospital Infantil Universitario Nino Jesus, Madrid · University Hospital Virgen Del Rocio S.L., Sevilla · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-03-30
NCT07334301
A Multi-Arm, Platform Trial For Relapsed Neuroblastoma
Trial Treatment · Phase 1/2 · University of Birmingham
Hospital Universitario de Cruces, Barakaldo · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Infantil Universitario Nino Jesus, Madrid · Hospital Universitario La Paz, Madrid · University Hospital Virgen Del Rocio S.L., Sevilla · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-01-12
NCT06485947
Study Combining Dinutuximab Beta With Two Chemotherapy Regimens in Neuroblastoma
Trial Treatment · Phase 1 · Princess Maxima Center for Pediatric Oncology
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2025-07-08
NCT04221035
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
Trial Treatment · Phase 3 · Gustave Roussy, Cancer Campus, Grand Paris
Hospital Universitario de Cruces, Barakaldo · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario Donostia, Donostia · Hospital Clínico Universitario Virgen de la Arrixaca, El Palmar, Murcia · Hospital Universitario La Paz, Madrid · Hospital Infantil Universitario Nino Jesus, Madrid · Hospital Materno-Infantil de Málaga (Hospital Regional Universitario de Málaga), Malaga · University Hospital Son Espases, Palma · Complejo Hospitalario Universitario, Santiago de Compostela · University Hospital Virgen Del Rocio S.L., Sevilla · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2025-06-26
NCT04903899
177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-risk Neuroblastoma
Trial Treatment · Phase 2 · Jakob Stenman
Hospital Sant Joan De Deu Barcelona, Esplugues de Llobregat
Registry updated 2025-02-11

All Neuroblastoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error